Stephens Inc Tekla Life Sciences Investors Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Stephens Inc holds 12,707 shares of HQL stock, worth $190,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,707

Previous 11,811 7.59%

Holding current value

$190,223

Previous $167,000 14.37%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$14.26 - $15.78 $12,776 - $14,138	896 Added 7.59%	12,707 $191,000
Q2 2024 Aug 06, 2024	SELL	$12.79 - $14.27 $4,450 - $4,965	-348 Reduced 2.86%	11,811 $167,000
Q1 2024 May 15, 2024	SELL	$13.38 - $14.33 $9,058 - $9,701	-677 Reduced 5.27%	12,159 $165,000
Q4 2023 Feb 13, 2024	BUY	$11.35 - $13.6 $14,618 - $17,516	1,288 Added 11.15%	12,836 $172,000
Q3 2023 Nov 14, 2023	SELL	$12.38 - $13.69 $1,176 - $1,300	-95 Reduced 0.82%	11,548 $144,000
Q2 2023 Aug 14, 2023	BUY	$13.13 - $14.17 $3,098 - $3,344	236 Added 2.07%	11,643 $157,000
Q1 2023 May 15, 2023	SELL	$13.37 - $14.94 $33,665 - $37,618	-2,518 Reduced 18.08%	11,407 $158,000
Q4 2022 Jan 25, 2023	SELL	$13.55 - $15.23 $1.05 Million - $1.18 Million	-77,220 Reduced 84.72%	13,925 $198,000
Q3 2022 Nov 02, 2022	BUY	$13.39 - $16.31 $644,969 - $785,620	48,168 Added 112.08%	91,145 $1.25 Million
Q2 2022 Aug 03, 2022	BUY	$13.11 - $17.02 $426,717 - $553,983	32,549 Added 312.13%	42,977 $612,000
Q1 2022 May 04, 2022	SELL	$15.35 - $19.29 $846,383 - $1.06 Million	-55,139 Reduced 84.1%	10,428 $172,000
Q4 2021 Mar 07, 2022	SELL	$18.5 - $21.59 $969,696 - $1.13 Million	-52,416 Reduced 44.43%	65,567 $1.26 Million
Q3 2021 Oct 27, 2021	BUY	$20.27 - $22.67 $38,472 - $43,027	1,898 Added 1.64%	117,983 $2.45 Million
Q2 2021 Aug 12, 2021	BUY	$19.14 - $21.44 $1.9 Million - $2.13 Million	99,524 Added 600.95%	116,085 $2.49 Million
Q1 2021 May 14, 2021	BUY	$19.31 - $22.07 $17,630 - $20,149	913 Added 5.83%	16,561 $326,000
Q4 2020 Feb 10, 2021	BUY	$16.8 - $20.21 $10,516 - $12,651	626 Added 4.17%	15,648 $309,000
Q3 2020 Nov 13, 2020	BUY	$16.71 - $19.06 $34,823 - $39,721	2,084 Added 16.11%	15,022 $264,000
Q2 2020 Aug 24, 2020	BUY	$14.22 - $18.38 $183,978 - $237,800	12,938 New	12,938 $232,000
Q1 2019 May 03, 2019	SELL	$15.5 - $17.9 $465,945 - $538,091	-30,061 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$13.99 - $20.35 $16,536 - $24,053	-1,182 Reduced 3.78%	30,061 $454,000
Q3 2018 Nov 14, 2018	BUY	$18.89 - $20.49 $136,215 - $147,753	7,211 Added 30.01%	31,243 $638,000
Q2 2018 Aug 10, 2018	BUY	$18.13 - $19.4 $13,253 - $14,181	731 Added 3.14%	24,032 $452,000
Q1 2018 May 03, 2018	BUY	$18.92 - $21.52 $196,295 - $223,270	10,375 Added 80.26%	23,301 $448,000
Q4 2017 Feb 05, 2018	SELL	$18.31 - $22.24 $1.01 Million - $1.22 Million	-55,058 Reduced 80.99%	12,926 $254,000
Q3 2017 Nov 08, 2017	BUY	$20.12 - $21.88 $1.37 Million - $1.49 Million	67,984	67,984 $1.46 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.03M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account